Loss of Purkinje cells in the PKCγ H101Y transgenic mouse

16Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Spinocerebellar ataxia type 14 (SCA14) is an autosomal, dominant neurodegenerative disorder caused by mutations in PKCγ. The objective of this study was to determine effects of PKCγ H101Y SCA14 mutation on Purkinje cells in the transgenic mouse. Results demonstrated that wild type PKCγ-like Purkinje cell localization of HA-tagged PKCγ H101Y mutant proteins, altered morphology and loss of Purkinje cells were observed in the PKCγ H101Y SCA14 transgenic mouse at four weeks of age. Failure of stereotypical clasping responses in the hind limbs of transgenic mice was also observed. Further, PKCγ H101Y SCA14 mutation caused lack of total cellular PKCγ enzyme activity, loss of connexin 57 phosphorylation on serines, and activation of caspase-12 in the PKCγ H101Y SCA14 transgenic mouse. Results clearly demonstrate a need for PKCγ control of gap junctions for maintenance of Purkinje cells. This is the first transgenic mouse to our knowledge which models a human SCA14 mutation. © 2008 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Zhang, Y., Snider, A., Willard, L., Takemoto, D. J., & Lin, D. (2009). Loss of Purkinje cells in the PKCγ H101Y transgenic mouse. Biochemical and Biophysical Research Communications, 378(3), 524–528. https://doi.org/10.1016/j.bbrc.2008.11.082

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free